Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
20041.4k citationsLars Klareskog, Désirée van der Heijde et al.The Lancetprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Marie Sanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Sanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Sanda more than expected).
This network shows the impact of papers produced by Marie Sanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Sanda. The network helps show where Marie Sanda may publish in the future.
Co-authorship network of co-authors of Marie Sanda
This figure shows the co-authorship network connecting the top 25 collaborators of Marie Sanda.
A scholar is included among the top collaborators of Marie Sanda based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Marie Sanda. Marie Sanda is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
15 of 15 papers shown
1.
Klareskog, Lars, Désirée van der Heijde, J Jäger, et al.. (2004). Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. The Lancet. 363(9410). 675–681.1408 indexed citations breakdown →
2.
Heijde, D. van der, Andrew Gough, Joachim R. Kalden, et al.. (2004). 31. SWITCHING BIOLOGICS AFTER INITIAL ANTI-TUMOUR NECROSIS FACTOR-α FAILURE; SUCCESS WITH FURTHER TNF-α ANTAGONISM BUT FAILURE ON SUBSEQUENT INTERLEUKIN-1 RECEPTOR ANTAGONIST.1 indexed citations
Paulus, Harold E., John T. Sharp, Harry K. Genant, et al.. (2004). Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.. PubMed. 31(3). 470–81.10 indexed citations
Paulus, Harold E., Marie Sanda, John Lynch, et al.. (2000). Progression of radiographic joint erosion during low dose corticosteroid treatment of rheumatoid arthritis.. PubMed. 27(7). 1632–7.23 indexed citations
Lanza, François, M F Rack, Melvyn Lynn, Jean‐Pierre Wolf, & Marie Sanda. (1987). An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen, and placebo on the gastrointestinal mucosa.. PubMed. 14(2). 338–41.68 indexed citations
Scatina, JoAnn, David Hicks, M. Kraml, et al.. (1986). Etodolac kinetics in the elderly. Clinical Pharmacology & Therapeutics. 39(5). 550–553.15 indexed citations
Kurebe, Masaru, et al.. (1985). [Preventive effect of fosfomycin on the renal toxicity of cisplatin].. PubMed. 38(1). 62–8.14 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.